<DOC>
	<DOCNO>NCT02979392</DOCNO>
	<brief_summary>The purpose study investigate safety determine maximum tolerate dose recommended phase 2 dose TENPA ( Targeting-Enhancing Nanoparticles Paclitaxel ) patient advance solid tumor .</brief_summary>
	<brief_title>Phase I Study TENPA Advanced Solid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . Willing able provide write informed consent voluntary participation trial 2 . Twenty year age old day signing inform consent 3 . Advanced solid tumor standard treatment available 4 . Evaluable disease measurable lesion 5 . ECOG performance score 0 1 6 . Life expectancy ≥ 12 week 7 . Adequate organ marrow function define : A . Absolute neutrophil count ( ANC ) ≥ 1.5 x 109/L ( &gt; 1500 per mm3 ) B. Haemoglobin ≥ 8.0 g/dL C. Platelet count ≥ 100 x 109/L ( &gt; 100,000 per mm3 ) D. AST ( SGOT ) /ALT ( SGPT ) ≤ 2.5 x institutional ULN E. Serum bilirubin ≤ 2 x institutional upper limit normal ( ULN ) F. Serum creatinine ≤ 1.5 mg/dL 8 . Adequate heart function A. QT interval correct heart rate ( QTc ) ≤ 480 m 9 . In opinion investigator likely willingness comply study protocol study period capable comply 10 . Negative serum pregnancy test ( β HCG ) upon study entry agree use contraception 1 . Uncontrolled CNS metastatic disease ( radiographically unstable symptomatic disease ) . ( note ) Subjects previously treat CNS metastasis ( surgery stereotactic brain radiation therapy ) radiographically stable least 4 week permit enroll . Subjects receive corticosteroid within 3 week prior study enrollment . 2 . History leptomeningeal carcinomatosis ; brain metastasis seizure control standard medical management . 3 . Major surgery within 4 week : patient must recover effect major surgery . 4 . History hematopoietic stem cell transplantation solid organ transplantation 5 . History Gilbert 's syndrome 6 . Prior malignancy except : Basal cell carcinoma squamous cell carcinoma skin undergone potentially curative surgery , situ cervical cancer undergone potentially curative surgery evidence recurrence least past 3 year , malignancy undergone curative surgery evidence disease least past 5 year . 7 . Significant cardiovascular disease , : history myocardial infarction , acute coronary syndrome coronary angioplasty/stenting/bypass graft within last 6 month ; History current evidence clinically significant arrhythmia conduction disorder , except symptomatic congestive heart failure ( CHR ) , atrial fibrillation , paroxysmal supraventricular tachycardia ( PSVT ) 8 . Sustained uncontrolled hypertension 9 . Test result indicate active infection human immunodeficiency virus ( HIR ) hepatitis B C , define positive serology test ( note ) inactive hepatitis B carrier antiviral agent permit enroll . 10 . Neuromuscular disorder associate CK elevation ( eg . Inflammatory myopathy , muscular dystrophy , amyotrophic lateral sclerosis , spinobulbar muscular atrophy ) 11 . Uncontrolled intercurrent illness symptom include , limited , ongoing active infection , bowel obstruction , psychiatric illness/social situation would limit compliance study requirement . 12 . Radiation therapy within 2 week first dose study drug : patient must recover effect radiation therapy 13 . Pregnant breast feeding . 14 . Female subject childbearing potential within project duration study , start screen visit 30 day last dose study drug . Female childbearing potential define surgically sterile ( i.3. , bilateral tubal ligation , bilateral oophorectomy , complete hysterectomy ) postmenopausal ( defined 12 month menses without alternative medical cause ) . Periodic abstinence , rhythm method , withdrawal method acceptable method birth control . 15 . Nonsterilized male sexually active female partner child bear potential screen 30 day receipt final dose study drug . 16 . Any medical , psychiatric cognitive disorder compromise ability subject give inform consent , comply study protocol , complete study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>